Authors: Kudelka, AP Verschraegen, CF Shen, Y De Leon, CG Edwards, CL Freedman, RS Forman, A Gibbs, HR Mante, R Hord, M Canetta, R Krakoff, I Kavanagh, JJ

Citation: Ap. Kudelka et al., Long-term results and pharmacokinetics of high-dose paclitaxel in patientswith refractory epithelial ovarian carcinoma, INT J GYN C, 9(1), 1999, pp. 44-53

Authors: Lebwohl, DE Canetta, R

Citation: De. Lebwohl et R. Canetta, New developments in chemotherapy of advanced breast cancer, ANN ONCOL, 10, 1999, pp. 139-146

Authors: Bishop, JF Dewar, J Toner, GC Smith, J Tattersall, MHN Olver, IN Ackland, S Kennedy, I Goldstein, D Gurney, H Walpole, E Levi, J Stephenson, J Canetta, R

Citation: Jf. Bishop et al., Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer, J CL ONCOL, 17(8), 1999, pp. 2355-2364

Authors: Ferrante, K Winograd, B Canetta, R

Citation: K. Ferrante et al., Promising new developments in cancer chemotherapy, CANC CHEMOT, 43, 1999, pp. S61-S68